Literature DB >> 7552234

Aggregation of insulin and its prevention by carbohydrate excipients.

M Katakam1, A K Banga.   

Abstract

Aggregation of peptide/protein drugs is of concern as it may lead to reduced bioactivity, immunogenic reactions, blockage of infusion pumps or unacceptable physical appearance. Aggregation of insulin and its prevention by carbohydrate excipients was investigated in this study. Aggregation was induced in solid-state by incubating with moisture at 37 degrees C, or in solution by lyophilization, shaking or multiple passage through a needle. Moisture-induced aggregation in solid state with bovine and human insulin resulted in soluble aggregates which were analyzed by light scattering technique. They were found to be noncovalent by size exclusion chromatography. Three of the four carbohydrate excipients used, i.e., dextrose, Emdex and hydroxypropyl beta-cyclodextrin minimized the moisture-induced aggregation of bovine insulin, with dextrose and Emdex being somewhat more effective. In lyophilization studies, bovine insulin was found to aggregate more than human insulin. In syringe/needle study, aggregation increased as a function of the number of times the solution was passed through the needle. Aggregation induced by shaking insulin solutions resulted in insoluble aggregation, which could also be minimized by carbohydrate excipients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552234

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  6 in total

1.  Inhibition of insulin fibrillogenesis with targeted peptides.

Authors:  Todd J Gibson; Regina M Murphy
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

2.  A solid-state NMR study of protein hydration and stability.

Authors:  F Separovic; Y H Lam; X Ke; H K Chan
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

3.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

Review 4.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

5.  Use of a small peptide fragment as an inhibitor of insulin fibrillation process: a study by high and low resolution spectroscopy.

Authors:  Victor Banerjee; Rajiv K Kar; Aritreyee Datta; Krupakar Parthasarathi; Subhrangsu Chatterjee; Kali P Das; Anirban Bhunia
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

Review 6.  Immunogenicity of therapeutic proteins: influence of aggregation.

Authors:  Kirsty D Ratanji; Jeremy P Derrick; Rebecca J Dearman; Ian Kimber
Journal:  J Immunotoxicol       Date:  2013-08-06       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.